ERecord Management, Inc.

ERecord Management, Inc. operates as a healthcare consulting company. It offers EMR solutions to healthcare providers in terms of health information systems and services; PMS solutions for enterprise appointment scheduling; and MRI solutions, which include MRI technology and PACS system software, as well as various installation, management, and daily staffing. The company also provides training, implementation, technical support, remote troubleshooting, and corporate office training services. ERecord Management focuses on solutions for electronic medical records, practice management systems, information technology security and audit services, and various other components of HIPAA compliance requirements. The company was founded in 2001. It was formerly known as R-Tec Technologies, Inc. and changed its name to ERecord Management, Inc. in January 2008. ERecord Management is based in Oak Park, California.

ERecord Management, Inc. trades as ERMG on OTC. The company is classified in Technology / Hardware, Equipment & Parts and reports in USD.

The current profile places the business in Hardware, Equipment & Parts. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $1.28M of revenue and -$1.18M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

ERecord Management, Inc. can be compared against peers such as Crayon Group Holding ASA, Fujimi Incorporated, FIH Mobile Limited, HTC Corporation, Learning Technologies Group plc, Magnet Forensics Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $22.59M, beta of 1.54, and return on equity of +115.6%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

ERMG currently shows total debt of $1.26M and beta of 1.54. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website is not available.

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.